Xeloda for colon cancer

July 2001

More patients will be taking Xeloda for colon cancer. It's the first ORAL treatment approved for metastatic colorectal cancer.

Xeloda (capecitabine) will be used as an alternative to IV 5-fluorouracil and leucovorin.

It slows disease progression and prolongs survival about the same as IV therapy...but Xeloda is much easier to take.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

recent meningitis outbreaks
if the FDA is going to pull Synthroid from the market
Stroke ACE inhibitors and diuretics can prevent recurrent stroke
Cardiology whether alpha blockers are safe for treating hypertension
Cardiology Treating anemia with erythropoietin seems to improve cardiac function in patients with moderate to severe heart failure
Lyme Disease one dose of doxycycline after a tick bite can PREVENT Lyme disease
Migraine new triptan for migraines called Axert (almotriptan)
Hematology & Oncology men who eat moderate amounts of fatty fish have a lower risk of prostate cancer
Hematology & Oncology Xeloda for colon cancer
Oral Health using pilocarpine eyedrops ORALLY to treat severe dry mouth
Alzheimer's Disease new guidelines that urge earlier intervention for Alzheimer's
Diabetes whether angiotensin receptor blockers should be used to prevent nephropathy in type 2 diabetes
Allegra-D tablets in their stool
Women's Health estrogen is effective for treating depression in perimenopausal women
Generics Many significant new generics will soon hit the market